The impact of comorbidity status in COVID-19 vaccines effectiveness before and after SARS-CoV-2 omicron variant in northeastern Mexico: a retrospective multi-hospital study

• Үндсэн зохиолчид: Maria Elena Camacho-Moll (Зохиогч), Viviana Leticia Mata-Tijerina (Зохиогч), Carlos Cuauhtémoc Gutiérrez-Salazar (Зохиогч), Beatriz Silva-Ramírez (Зохиогч), Katia Peñuelas-Urquides (Зохиогч), Laura González-Escalante (Зохиогч), Brenda Leticia Escobedo-Guajardo (Зохиогч), Jorge Eleazar Cruz-Luna (Зохиогч), Roberto Corrales-Pérez (Зохиогч), Salvador Gómez-García (Зохиогч), Mario Bermúdez-de León (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

IntroductionThe end of the coronavirus disease 2019 (COVID-19) pandemic has been declared by the World Health Organization on May 5, 2023. Several vaccines were developed, and new data is being published about their effectiveness. However, the clinical trials for the vaccines were performed before t...